Radiation Oncology

Researchers unveiled an AI model at the ASTRO Annual Meeting that accurately predicts biochemical recurrence in prostate cancer patients following radiation therapy. The tool uses pre-treatment MRI scans and clinical data to outperform traditional risk models. This advancement could help tailor treatments more effectively.